Literature DB >> 6707517

Intestinal lipoprotein synthesis. Comparison of nascent Golgi lipoproteins from chow-fed and hypercholesterolemic rats.

L L Swift, P D Soulé, M E Gray, V S LeQuire.   

Abstract

Hypercholesterolemia, induced by a cholesterol-enriched diet, is associated with distinctive modifications in the serum lipoproteins of a variety of species. Present in the serum of these animals are several classes of lipoproteins enriched in cholesteryl esters and apolipoprotein E. To investigate the role of intestinal lipoprotein synthesis in diet-induced hypercholesterolemia, we characterized nascent lipoproteins retrieved from Golgi apparatus-rich fractions of intestinal epithelial cells from chow-fed control and hypercholesterolemic rats. To eliminate chylomicrons from the preparations, rats were fasted overnight prior to the experiments. Golgi very low density lipoproteins (d less than 1.006 g/ml) from control rats were triglyceride-rich lipoproteins that migrated slightly slower than pre-beta migrating serum very low density lipoproteins. These particles contained apoproteins B-240, A-IV, and A-I. Golgi very low density lipoproteins from hypercholesterolemic rats were likewise triglyceride-rich lipoproteins migrating electrophoretically like control Golgi very low density lipoproteins and they contained apoproteins B-240, A-IV, and A-I. However, these latter particles contained less triglyceride and more cholesterol compared to control Golgi very low density lipoproteins. In addition, by radioisotope incorporation studies, Golgi very low density lipoproteins from hypercholesterolemic rats contained relatively more apoprotein A-IV (21.6 vs. 11.0%) and less apoprotein B-240 (17.0 vs. 27.0%) than found in control Golgi very low density lipoproteins. Approximately 60% of the total apoprotein radioactivity was found in apoprotein A-I in both preparations. We conclude that intestinal lipoprotein synthesis is modified by diet-induced hypercholesterolemia. The significance of these modifications with respect to the marked hypercholesterolemia observed in these animals remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707517

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  The assembly of lipids into lipoproteins during secretion.

Authors:  J E Vance; D E Vance
Journal:  Experientia       Date:  1990-06-15

2.  The cholesterol-lowering property of soybeans fed to rats is related to the fasting duration.

Authors:  L Guermani-Nicolle; C Villaume; H M Bau; A Schwertz; J P Nicolas; L Mejean
Journal:  Plant Foods Hum Nutr       Date:  2001       Impact factor: 3.921

3.  Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding.

Authors:  M F Go; G Schonfeld; B Pfleger; T G Cole; N L Sussman; D H Alpers
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

4.  Effect of pluronic L-81 on intestinal lipoprotein secretion in the rat.

Authors:  J Pidlich; F Renner; A Ellinger; M Hüttinger; M Pavelka; A Gangl
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

5.  A possible role for rat intestinal surfactant-like particles in transepithelial triacylglycerol transport.

Authors:  A Mahmood; F Yamagishi; R Eliakim; K DeSchryver-Kecskemeti; T L Gramlich; D H Alpers
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

6.  Effect of marginal zinc deficiency on the apolipoprotein-B content and size of mesenteric lymph chylomicrons in adult rats.

Authors:  S I Koo; C C Lee; J E Norvell
Journal:  Lipids       Date:  1987-12       Impact factor: 1.880

7.  Isolation of high density lipoproteins from rat intestinal epithelial cells.

Authors:  A M Magun; T A Brasitus; R M Glickman
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Rat intestinal apolipoprotein B gene expression. Evidence for integrated regulation by bile salt, fatty acid, and phospholipid flux.

Authors:  N O Davidson; M J Drewek; J I Gordon; J Elovson
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.